New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive treatments—such as monoclonal antibodies—sooner.
Most children SMA type 1 can survive an episode of pARDS, a life-threatening respiratory failure, under standard protocols, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback